Lantern Pharma LTRN
NASDAQ LTRN
$0.57 +0.04 (+6.75%)
At close: Nov 6, 2026 · 4:00 PM EST

Lantern Pharma (LTRN) Long-Term Debt Repayments (2020)

Updated

Lantern Pharma (LTRN) posted Long-Term Debt Repayments of $12,953 for Q1 2020.

Analysis

Lantern Pharma (LTRN) Long-Term Debt Repayments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 1.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -4.91 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Lantern Pharma 7.18 Mn -28.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 12,953.00
API Access

Lantern Pharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=LTRN&period=max&api_key=YOUR_API_KEY